Clinical Trials
155 trialsNCT00001163 2026-06-05
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
National Institutes of Health Clinical Center (CC)
Active not recruiting
NCT04606381 2026-06-05
PALOMA
Janssen Research & Development, LLC
Phase 1 Active not recruiting
NCT06894849 2026-06-05
OASIS1
Medical University of South Carolina
Phase NA Active not recruiting
NCT04122469 2026-06-04
RADIANT
University Health Network, Toronto
Phase NA Active not recruiting
NCT01806129 2026-06-03
EROS
Eastern Cooperative Oncology Group
Phase NA Active not recruiting
NCT07159815 2026-06-01
REACT
Inland Norway University of Applied Sciences
Phase NA Active not recruiting
NCT00463814 2026-05-29
AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid Malignancies
AstraZeneca
Phase 1 Active not recruiting
NCT06593522 2026-05-28
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Amgen
Phase 2 Active not recruiting
NCT03180827 2026-05-27
Female Fertility Preservation Using Ovarian Tissue Cryopreservation Before Highly Gonadotoxic Cancer Treatment
University Hospital, Geneva
Phase NA Active not recruiting
NCT04958239 2026-05-27
A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer
Boehringer Ingelheim
Phase 1 Active not recruiting
NCT07218848 2026-05-22
ProSalud in Latinos Living in Rural/Agricultural Communities Within Moffitt's Catchment Area
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Active not recruiting
NCT06230016 2026-05-20
APADHOP
University Hospital, Grenoble
Active not recruiting
NCT04917848 2026-05-18
A Study of a Telemedicine Program for Older Adults With Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
NCT05656651 2026-05-15
ACTIVE
Universität Duisburg-Essen
Phase 2 Active not recruiting
NCT05155605 2026-05-14
PATHFINDER 2: A Multi-Cancer Early Detection Study
GRAIL, Inc.
Phase NA Active not recruiting
NCT02908906 2026-05-08
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
Janssen Research & Development, LLC
Phase 1/2 Active not recruiting
NCT04627246 2026-05-08
Personalized Vaccine With SOC Chemo Followed by Nivo in Pancreatic Cancer
Centre Hospitalier Universitaire Vaudois
Phase 1 Active not recruiting
NCT06559228 2026-05-08
ConnectedNest: a Digital Platform Connecting Individuals With Cancer to Social Care
University of Minnesota
Phase 2 Active not recruiting
NCT06555744 2026-05-07
A Study of ZW191 in Participants With Solid Tumors
Zymeworks BC Inc.
Phase 1 Active not recruiting
NCT05126823 2026-05-05
Efficacy of a Combined ACT+ App Intervention to Improve Psychological Flexibility and Associated Symptoms in Cancer Patients
Universidad de Córdoba
Phase NA Active not recruiting
NCT03857620 2026-04-30
Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer
Alliance for Clinical Trials in Oncology
Phase NA Active not recruiting
NCT05378425 2026-04-30
A Study of NTX-1088, a Monoclonal Antibody Targeting the Poliovirus Receptor (PVR, CD155), as Monotherapy and Combined With Pembrolizumab
Nectin Therapeutics Ltd
Phase 1 Active not recruiting
NCT03223766 2026-04-29
Evaluation of Proton Therapy in Pediatric Cancer Patients
St. Jude Children's Research Hospital
Active not recruiting
NCT04125095 2026-04-29
Estimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric Images
St. Jude Children's Research Hospital
Active not recruiting
NCT05305950 2026-04-29
Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors
M.D. Anderson Cancer Center
Active not recruiting
NCT03768063 2026-04-28
IMbrella B
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT07554157 2026-04-28
PanCanBlood
Zhejiang Cancer Hospital
Active not recruiting
NCT05886764 2026-04-27
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
University of Chicago
Phase NA Active not recruiting
NCT05342155 2026-04-24
Patient- Generated Health Data to Predict Childhood Cancer Survivorship Outcomes
St. Jude Children's Research Hospital
Active not recruiting
NCT06077877 2026-04-24
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors
GlaxoSmithKline
Phase 1/2 Active not recruiting
NCT07011862 2026-04-24
COBRA: Cancer, Older Adults, Balance and Resistance Activities
Memorial Sloan Kettering Cancer Center
Phase NA Active not recruiting
NCT04050072 2026-04-23
Patient-Reported Outcome Version of the Common Criteria for Adverse Events
St. Jude Children's Research Hospital
Active not recruiting
NCT04452955 2026-04-22
A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors
Intra-IMMUSG Pte Ltd
Phase 2 Active not recruiting
NCT02646384 2026-04-20
Ovarian Tissue Cryopreservation in Children
Mayo Clinic
Phase NA Active not recruiting
NCT02243592 2026-04-17
Molecular Profiling in Tissue Samples From Patients With Cancer Who Are Exceptional Responders to Treatment
National Cancer Institute (NCI)
Active not recruiting
NCT02911064 2026-04-16
Expectations Regarding Mobility and Self-Care
M.D. Anderson Cancer Center
Active not recruiting
NCT05836857 2026-04-16
The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study
M.D. Anderson Cancer Center
Active not recruiting
NCT02337452 2026-04-15
Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families
M.D. Anderson Cancer Center
Active not recruiting
NCT04464226 2026-04-15
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
Bayer
Phase 3 Active not recruiting
NCT03768336 2026-04-14
A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors
Massachusetts General Hospital
Phase NA Active not recruiting
NCT05611632 2026-04-14
NHS-Galleri
GRAIL, Inc.
Phase NA Active not recruiting
NCT03148418 2026-04-13
A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT05993299 2026-04-08
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
USWM, LLC (dba US WorldMeds)
Phase 2 Active not recruiting
NCT06703346 2026-04-08
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma
USWM, LLC (dba US WorldMeds)
Phase 2 Active not recruiting
NCT05112965 2026-04-06
An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)
Hoffmann-La Roche
Phase 3 Active not recruiting
NCT05629234 2026-04-06
ROSY-T
AstraZeneca
Phase 3 Active not recruiting
NCT05784766 2026-04-06
SARIC
University of Oklahoma
Phase NA Active not recruiting
NCT02584933 2026-04-02
Roll-over Study to Allow Access to Certinib (LDK378) for Patients Who Are on Ceritinib Treatment in a Novartis-sponsored Study
Novartis
Phase 4 Active not recruiting
NCT06018753 2026-04-02
Polaris
Tempus AI
Active not recruiting
NCT06926972 2026-04-01
NOURISH
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Active not recruiting